Michael Atkins
迈克尔·阿特金斯
MD
Deputy Director and Professor of Oncology副主任兼肿瘤学教授
👥Biography 个人简介
Michael Atkins is a pioneer of high-dose IL-2 therapy for melanoma and renal cell carcinoma, and a leading authority on immunotherapy toxicity management and biomarker development. His decades of work established cytokine therapy foundations that informed modern checkpoint immunotherapy.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
High-Dose IL-2 Immunotherapy
Established high-dose IL-2 as a curative option for a subset of metastatic melanoma and renal cell carcinoma patients, obtaining FDA approval and defining patient selection criteria for durable complete responses.
Immunotherapy Toxicity Management
Developed comprehensive frameworks for identifying, grading, and managing immune-related adverse events from checkpoint inhibitors, now incorporated into national and international clinical guidelines.
Predictive Biomarkers
Identified tumor microenvironment and genomic biomarkers predicting response to immunotherapy and BRAF inhibitors in melanoma, advancing precision selection of therapeutic strategies.
Representative Works 代表性著作
High-Dose Recombinant Interleukin-2 Therapy for Metastatic Melanoma
Journal of Clinical Oncology (1999)
Definitive analysis establishing high-dose IL-2 as capable of inducing durable complete remissions in metastatic melanoma.
Pembrolizumab versus Ipilimumab for Advanced Melanoma
New England Journal of Medicine (2015)
Co-author of KEYNOTE-006 trial establishing pembrolizumab as the new standard over ipilimumab.
Combination Dabrafenib and Trametinib versus Dabrafenib Monotherapy in Melanoma (COMBI-d)
The Lancet (2015)
Randomized trial demonstrating OS benefit of BRAF/MEK combination over BRAF inhibitor alone in advanced melanoma.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
University of California, Los Angeles
Caroline Robert
Institut Gustave Roussy
Paolo Antonio Ascierto
Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples
Reinhard Dummer
University Hospital Zurich
关注 迈克尔·阿特金斯 的研究动态
Follow Michael Atkins's research updates
留下邮箱，当我们发布与 Michael Atkins（Georgetown Lombardi Comprehensive Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment